aluminum sulfate has been researched along with Respiratory Syncytial Virus Infections in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halperin, S; Kaliaperumal, V; Langley, JM; MacDonald, LD; MacKay, A; Mansour, M; Penwell, A; Rajagopalan, R; Stanford, MM; Weir, G | 1 |
| Halperin, SA; Langley, JM; MacDonald, LD; MacKinnon-Cameron, D; McNeil, S; Saelens, X; Schepens, B; Stanford, MM; Weir, GM; Ye, L | 1 |
| Hwang, HS; Jeeva, S; Jung, YJ; Kang, SM; Kim, KH; Ko, EJ; Kwon, YM; Lee, Y; Lee, YT; Seong, BL | 1 |
| Hwang, HS; Jung, YJ; Kang, SM; Kim, KH; Kwon, YM; Lee, JS; Lee, Y; Lee, YN; Lee, YT; Park, S | 1 |
| Aggarwal, N; Dewé, W; Dieussaert, I; Fissette, L; Halperin, SA; Langley, JM; Leyssen, M; McNeil, SA; Toma, A; Toussaint, JF | 1 |
| Bennett, AS; Cayatte, C; Cheng, L; Hostetler, L; McCarthy, MP; McTamney, P; Nacel, K; O'Day, T; Prince, GA; Rajani, GM; Ren, K; Schneider-Ohrum, K | 1 |
| Capellan, J; Edelman, R; Falsey, AR; Gorse, GJ; Gravenstein, S; Hayden, FG; McElhaney, JE; Neuzil, KM; Nichol, KL; Sales, VM; Simões, EA; Walsh, EE; Wright, PF; Yau, E; Zambon, M | 1 |
| Anderson, R; Huang, Y | 1 |
| Edwards, L; Hussell, T; Lloyd, CM; Mathie, S; Openshaw, PJ; Schwarze, J; Tourdot, S; Wang, H | 1 |
| Gar, N; Graham, BS; Johnson, JE; Neuzil, KM; Prieels, JP; Slaoui, M; Tang, YW | 1 |
3 trial(s) available for aluminum sulfate and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.
Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Viral; Drug-Related Side Effects and Adverse Reactions; Female; Healthy Volunteers; Humans; Immunity, Humoral; Immunization Schedule; Lipids; Male; Middle Aged; Placebos; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; Retroviridae Proteins, Oncogenic; Single-Blind Method; Vaccines, Subunit | 2018 |
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Alum Compounds; Antibodies, Neutralizing; Antibodies, Viral; Antigens, Viral; Female; Humans; Male; Pregnancy; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; Vaccines, Synthetic; Viral Fusion Proteins; Young Adult | 2017 |
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals.
Topics: Aged; Aged, 80 and over; Alum Compounds; Double-Blind Method; Female; Humans; Male; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; United States | 2008 |
7 other study(ies) available for aluminum sulfate and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Delayed-Action Preparations; Drug Evaluation, Preclinical; Epitopes, B-Lymphocyte; Female; Immune Complex Diseases; Immunogenicity, Vaccine; Incidence; Mice; Oils; Rabbits; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Viruses; Vaccination; Vaccines, Subunit; Vaccines, Synthetic | 2018 |
The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Cell Line; Humans; Immunoglobulin G; Lipid A; Lung; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; Th1 Cells; Vaccines, Inactivated; Viral Load | 2019 |
Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.
Topics: Adaptive Immunity; Adjuvants, Immunologic; Alum Compounds; Animals; CD4-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunity, Innate; Immunization; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pneumonia; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; T-Lymphocytes, Helper-Inducer; Viral Vaccines | 2015 |
Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antibody-Dependent Enhancement; Disease Models, Animal; Lipid A; Recombinant Proteins; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Sigmodontinae; Th1 Cells; Th2 Cells; Vaccines, Synthetic; Viral Fusion Proteins | 2017 |
Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Cytokines; Eosinophilia; Lung; Mice; Mutagenesis, Site-Directed; Mutation; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Viruses; RNA, Messenger; Vaccines, Synthetic; Viral Proteins | 2005 |
Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.
Topics: Alum Compounds; Analysis of Variance; Animals; Asthma; Bronchoalveolar Lavage Fluid; Collagen; Cytokines; Extracellular Matrix; Female; Fibroblast Growth Factor 2; Immunohistochemistry; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Statistics, Nonparametric; Transforming Growth Factor beta | 2008 |
Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Antibody Specificity; Antigen-Antibody Reactions; Cytokines; Female; Immunization; Immunoglobulin Isotypes; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Viral Vaccines; Virus Replication | 1997 |